Genfit CEO Prigent outlines Iqirvo outlook after Ipsen H1 results

Reuters2026/08/03 14:38

By:Reuters

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Genfit management released a Q&A video interview on Aug. 3, 2026, featuring CEO Pascal Prigent.
Prigent discussed Iqirvo prospects following Ipsen’s first-half 2026 results published on July 30.
The interview also addressed shareholder questions on elafibranor in PBC and PSC.
Genfit’s non-invasive diagnostic technology development in MASH was also covered.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Genfit SA published the original content used to generate this news brief on August 03, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Genfit CEO Prigent outlines Iqirvo outlook after Ipsen H1 results

You may also like

Crypto prices